2012
DOI: 10.1371/journal.pone.0052591
|View full text |Cite
|
Sign up to set email alerts
|

Antigen Recognition By Autoreactive Cd4+ Thymocytes Drives Homeostasis Of The Thymic Medulla

Abstract: The thymic medulla is dedicated for purging the T-cell receptor (TCR) repertoire of self-reactive specificities. Medullary thymic epithelial cells (mTECs) play a pivotal role in this process because they express numerous peripheral tissue-restricted self-antigens. Although it is well known that medulla formation depends on the development of single-positive (SP) thymocytes, the mechanisms underlying this requirement are incompletely understood. We demonstrate here that conventional SP CD4+ thymocytes bearing a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
29
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(37 citation statements)
references
References 47 publications
7
29
0
1
Order By: Relevance
“…In particular, CD40L, RANKL and LTαβ have all been shown to be upregulated on SP thymocytes relative to DN and DP thymocytes (6); and mice lacking RANK-RANKL, LTαβ-LTβR or CD40-CD40L interactions have mTEC compartment defects of varying severities (6, 25, 38, 40, 41). Consistent with recent reports (37, 52), we found that expression of LTαβ on CD4 SP thymocytes is decreased in the absence of CD28-CD80/86 interactions. Our finding that LTβR/CD40 combined KO mice have a more profound mTEC defect than either the LTβR or CD40 single KOs suggests that CD28-CD80/86 cooperates with CD40-CD40L interactions to promote mTEC development, in part via increased LTαβ production by CD4 SP thymocytes.…”
Section: Discussionsupporting
confidence: 93%
“…In particular, CD40L, RANKL and LTαβ have all been shown to be upregulated on SP thymocytes relative to DN and DP thymocytes (6); and mice lacking RANK-RANKL, LTαβ-LTβR or CD40-CD40L interactions have mTEC compartment defects of varying severities (6, 25, 38, 40, 41). Consistent with recent reports (37, 52), we found that expression of LTαβ on CD4 SP thymocytes is decreased in the absence of CD28-CD80/86 interactions. Our finding that LTβR/CD40 combined KO mice have a more profound mTEC defect than either the LTβR or CD40 single KOs suggests that CD28-CD80/86 cooperates with CD40-CD40L interactions to promote mTEC development, in part via increased LTαβ production by CD4 SP thymocytes.…”
Section: Discussionsupporting
confidence: 93%
“…Our findings are consistent with the recent report that combined stimulation of 2-dGUO-treated thymic lobes with agonist anti-LTβR antibody and CD40L synergized in the in vitro induction of mTECs (28), importantly extending these findings by demonstrating that LTβR and CD40L pathways, in fact, interact cooperatively during in vivo thymic development as evidenced by the severe reduction in mTEC numbers we observed in mice deficient in both pathways.…”
Section: Discussionsupporting
confidence: 93%
“…This suggests that reduced thymic cDC cellularity in NOD.TCRα −/− mice is due to a developmental defect in the absence of SP, which may be especially relevant for intrathymically-derived CD8α + cDC. It is possible that mTEC, which are also reduced in TCRα −/− mice (28, 29, 32), contribute to thymic cDC cellularity and maturation. mTEC may provide a niche through production of chemokines such as XCL1 and CCL8 or other factors that regulate thymic cDC localization, recruitment, and/or maturation (17, 21, 33).…”
Section: Resultsmentioning
confidence: 99%
“…mTEC may provide a niche through production of chemokines such as XCL1 and CCL8 or other factors that regulate thymic cDC localization, recruitment, and/or maturation (17, 21, 33). However, thymic DC numbers are normal in β2M- or MHC II-deficient mice, the latter exhibiting a reduced mature mTEC pool (29, 32). These findings illustrate 2 key points: 1) either SPCD4 or SPCD8 are sufficient to sustain DC homeostasis, consistent with our findings in peptide-treated BDC2.5/TCRα −/− and CL4.…”
Section: Resultsmentioning
confidence: 99%